{"id":814121,"date":"2025-02-18T08:37:59","date_gmt":"2025-02-18T13:37:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/"},"modified":"2025-02-18T08:37:59","modified_gmt":"2025-02-18T13:37:59","slug":"healthedge-announces-successful-sale-of-lifesync-to-amphenol","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/","title":{"rendered":"HealthEdge Announces Successful Sale of LifeSync to Amphenol"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n TAMPA, Fla.<\/span> and CORAL SPRINGS, Fla.<\/span><\/span>, Feb. 18, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0HealthEdge Investment Partners, LLC (“HealthEdge”), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync (“LifeSync” or the “Company”), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE: APH), one of the world’s largest providers of connectors, interconnect systems, antennas, sensors and specialty cable.<\/p>\n

“When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial business with a great product and unique IP,” said Brian Anderson<\/span>, Managing Partner of HealthEdge. “We accomplished our goals and more by appointing a new management team, completing four acquisitions that added complementary products and vertically integrated manufacturing, and reorganizing the company into its neuro, cardio, and contract manufacturing divisions. In the process, LifeSync touched millions of patients with its products, and grew revenues from $5 million<\/span> to approximately $100 million<\/span>. Given the strong organic and acquisitive growth of the Company, this exit yielded strong investment returns for HealthEdge Fund II.”<\/p>\n

“I am proud of the growth LifeSync has accomplished and the work our global team does each day to provide critical medical products to hospitals,” added Bob Buehler<\/span>, General Manager of LifeSync. “HealthEdge has been an invaluable partner to LifeSync as the Company has evolved during my tenure as CEO. We are excited to join Amphenol and work on the Company’s future growth plans.”<\/p>\n

Hill Ward Henderson<\/span> acted as legal counsel and Lincoln International LLC served as financial advisor to LifeSync on the sale.<\/p>\n

\n ABOUT HEALTHEDGE<\/b>\n <\/p>\n

HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined experience in healthcare as operators and investors. For more information on HealthEdge, please visit www.healthedgepartners.com<\/a>.<\/p>\n

\n ABOUT LIFESYNC<\/b>\n <\/p>\n

LifeSync is the only vertically integrated company focused solely on patient connections, providing cardiac cables, leadwires and neuromonitoring connections in addition to contract manufacturing solutions. Headquartered in Coral Springs, FL<\/span>, LifeSync develops and manufactures products at its state-of-the-art manufacturing capabilities.<\/p>\n

\n ABOUT AMPHENOL<\/b>\n <\/p>\n

Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.\u00a0 Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors.\u00a0 Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit www.amphenol.com<\/a>.<\/p>\n

CONTACT:
HealthEdge Investment Partners, LLC
5550 W. Executive Drive, Suite 230
Tampa, Florida<\/span> 33609
(813) 490-7100
www.healthedgepartners.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/healthedge-announces-successful-sale-of-lifesync-to-amphenol-302378866.html<\/a><\/p>\n

SOURCE HealthEdge Investment Partners, LLC<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 \/PRNewswire\/ —\u00a0HealthEdge Investment Partners, LLC (“HealthEdge”), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync (“LifeSync” or the “Company”), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE: APH), one of the world’s largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. “When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial business with a great product and unique IP,” said Brian Anderson, Managing Partner of HealthEdge. “We accomplished our goals … <\/p>\n

Continue reading “HealthEdge Announces Successful Sale of LifeSync to Amphenol”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-814121","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHealthEdge Announces Successful Sale of LifeSync to Amphenol - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HealthEdge Announces Successful Sale of LifeSync to Amphenol - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 \/PRNewswire\/ —\u00a0HealthEdge Investment Partners, LLC (“HealthEdge”), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync (“LifeSync” or the “Company”), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE: APH), one of the world’s largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. “When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial business with a great product and unique IP,” said Brian Anderson, Managing Partner of HealthEdge. “We accomplished our goals … Continue reading "HealthEdge Announces Successful Sale of LifeSync to Amphenol"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T13:37:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=FL21129&sd=2025-02-18\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HealthEdge Announces Successful Sale of LifeSync to Amphenol\",\"datePublished\":\"2025-02-18T13:37:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/\"},\"wordCount\":529,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=FL21129&sd=2025-02-18\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/\",\"name\":\"HealthEdge Announces Successful Sale of LifeSync to Amphenol - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=FL21129&sd=2025-02-18\",\"datePublished\":\"2025-02-18T13:37:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=FL21129&sd=2025-02-18\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=FL21129&sd=2025-02-18\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HealthEdge Announces Successful Sale of LifeSync to Amphenol\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HealthEdge Announces Successful Sale of LifeSync to Amphenol - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/","og_locale":"en_US","og_type":"article","og_title":"HealthEdge Announces Successful Sale of LifeSync to Amphenol - Market Newsdesk","og_description":"PR Newswire TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 \/PRNewswire\/ —\u00a0HealthEdge Investment Partners, LLC (“HealthEdge”), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync (“LifeSync” or the “Company”), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE: APH), one of the world’s largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. “When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial business with a great product and unique IP,” said Brian Anderson, Managing Partner of HealthEdge. “We accomplished our goals … Continue reading \"HealthEdge Announces Successful Sale of LifeSync to Amphenol\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-18T13:37:59+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=FL21129&sd=2025-02-18","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HealthEdge Announces Successful Sale of LifeSync to Amphenol","datePublished":"2025-02-18T13:37:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/"},"wordCount":529,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=FL21129&sd=2025-02-18","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/","name":"HealthEdge Announces Successful Sale of LifeSync to Amphenol - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=FL21129&sd=2025-02-18","datePublished":"2025-02-18T13:37:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=FL21129&sd=2025-02-18","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=FL21129&sd=2025-02-18"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/healthedge-announces-successful-sale-of-lifesync-to-amphenol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HealthEdge Announces Successful Sale of LifeSync to Amphenol"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=814121"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814121\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=814121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=814121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=814121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}